Comparisons of different lentiviral vectors used for gene therapy of β-thalassemia.
| . | Transgene . | Rise in Hb/Vector Copy . | Summary of Findings . |
|---|---|---|---|
| May et al28 | β-globin | 3.8 gm | Correction of anemia in thalassemia intermedia mice |
| Imren et al29 | β87-globin | 1.5 gm | Correction of anemia in thalassemia intermedia mice |
| Rivella et al32 | β-globin | 2.3 gm | Rescue of lethality in a thalassemia major mouse model |
| Persons et al31 | γ-globin | 1.1 gm | Correction of anemia in thalassemia intermedia mice |
| Hanawa et al33 | γ-globin | 2.0 gm | Correction of anemia in thalassemia intermedia mice Reduced position effects |
| Imren et al42 | β87-globin | — | High level expression of an antisickling ß87 globin in human erythroid cells derived from cord blood progenitors in immune deficient mice Integration of vector near potential oncogenes |
| Puthenveetil et al34 | β-globin | — | Correction of Human β-thalassemia major phenotype in vitro and in immune deficient mice Reduced position effects |
| . | Transgene . | Rise in Hb/Vector Copy . | Summary of Findings . |
|---|---|---|---|
| May et al28 | β-globin | 3.8 gm | Correction of anemia in thalassemia intermedia mice |
| Imren et al29 | β87-globin | 1.5 gm | Correction of anemia in thalassemia intermedia mice |
| Rivella et al32 | β-globin | 2.3 gm | Rescue of lethality in a thalassemia major mouse model |
| Persons et al31 | γ-globin | 1.1 gm | Correction of anemia in thalassemia intermedia mice |
| Hanawa et al33 | γ-globin | 2.0 gm | Correction of anemia in thalassemia intermedia mice Reduced position effects |
| Imren et al42 | β87-globin | — | High level expression of an antisickling ß87 globin in human erythroid cells derived from cord blood progenitors in immune deficient mice Integration of vector near potential oncogenes |
| Puthenveetil et al34 | β-globin | — | Correction of Human β-thalassemia major phenotype in vitro and in immune deficient mice Reduced position effects |